Cook Medical inks deal to distribute Taewoong Medical Niti-S esophageal stents
Cook Medical said today that it inked a collaborative deal with South Korean Taewoong Medical to distribute a selection of the company’s stents in the U.S.
The deal includes Taewoong’s Niti-S Through The Scope esophageal stent, which is the flagship product of the company’s Niti-S self-expandable line of metal gastrointestinal stents, Cook said.
The Niti-S TTS esophageal stent is intended for use in treating certain esophageal strictures caused by malignant tumors, Bloomington, Ind.-based Cook Medical said. The system is deployed through a 10.5 French delivery system which Cook said is unique to the U.S. market, and allows the system to be introduced and placed through a scope with a conical tip intended to navigate through tight strictures and tortuous anatomies.
“We are very pleased and proud to enter into this collaboration with Cook Medical, a leading global medical device company. We believe Cook Medical’s philosophy and focus towards continuous innovation in product development is akin to Taewoong Medical’s own philosophy. And I am confident that our partnership will bring the optimal stent solutions to our U.S. doctors and patients,” Taewoong Medical CEO Kyongmin Shin said in a press release.
Cook Medical said that in addition to the Niti-S TTS stent, it will also distribute the standard non-TTS version of the stent, as well as the Niti-S biliiary stent.
“We’re excited to now be offering these stents and to continue our focus ...
Source: Mass Device - Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Stents Cook Medical taewoongmedical Source Type: news
More News: Cancer & Oncology | Endoscopy | Esophagus Cancer | France Health | Gastroenterology | Medical Devices | Partnerships | South Korea Health | Warnings